Pfizer (PFE) Dividends payables (QoQ) (2009 - 2021)
Powered by 
Analysis
Pfizer (PFE) Dividends payables (QoQ) (2009 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 2.65% |
| Oct 3, 2021 | 0.32% |
| Dec 31, 2020 | 2.37% |
| Sep 27, 2020 | 0.05% |
| Dec 31, 2019 | 5.62% |
| Sep 29, 2019 | 0.05% |
| Dec 31, 2018 | 4.28% |
| Sep 30, 2018 | -0.86% |
| Dec 31, 2017 | 6.29% |
| Oct 1, 2017 | 0.26% |
| Dec 31, 2016 | 6.75% |
| Oct 2, 2016 | 0.05% |
| Jun 29, 2014 | 164,900.00% |
| Mar 30, 2014 | -99.94% |
| Dec 31, 2013 | 166,200.00% |
| Sep 29, 2013 | -99.94% |
| Jun 30, 2013 | 33,600.00% |
| Mar 31, 2013 | -99.71% |
| Dec 31, 2012 | 173,200.00% |
| Sep 30, 2012 | -99.95% |